Enclosed is disclosure with respect to change in directors of the company.

II<S HEAL TH August 5, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Directors. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform that the Board of Directors of Inventurus Knowledge Solutions Limited (“the Company”) at its meeting held today, i.e., August 5, 2026, inter alia, considered and approved the following: 1. Retirement of Mr. Berjis Desai, Non-Executive Chairman and Non-Independent Director (DIN: 00153675) with effect from conclusion of ensuing 20th Annual General Meeting (AGM): Mr. Berjis Desai (DIN: 00153675), Non-Executive Chairman and Non-Independent Director of the Company, is liable to retire by rotation at the ensuing 20th Annual General Meeting ("AGM") of the Company. Mr. Desai has, vide his letter dated August 5, 2026, expressed his unwillingness to seek re- appointment at the ensuing AGM. Accordingly, he shall cease to be a Director and Non-Executive Chairman of the Company upon the conclusion of the ensuing 20th AGM. The disclosure as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026 is enclosed herewith as “Annexure -A”. A copy of letter received from Mr. Berjis Desai is enclosed herewith as “Annexure – B”. Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 II<S HEAL TH 2. Designate Mr. Clarence Carleton King II, Independent Director as Non-Executive Chairman and Independent Director of the Company with effect from conclusion of ensuing 20th Annual General Meeting (AGM): The Board has designated Mr. Clarence Carleton King II (DIN: 08171208), Independent Director of the Company, as the Non-Executive Chairman and Independent Director of the Company, with effect from the conclusion of the ensuing 20th AGM, consequent to the retirement of Mr. Berjis Desai as Non-Executive Chairman and Non-Independent Director. The disclosure as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026 is enclosed herewith as “Annexure -C”. The Board Meeting commenced at 07:15 P.M. IST and concluded at 08:44 P.M. IST. The aforementioned information is also available on the Company’s website at https://ikshealth.com/investor-relations/. Kindly take the above information on record. Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 II<S HEAL TH Annexure - A DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026 Disclosure of Change in Director Sr. No. Particulars Details 1. Name of Director Berjis Desai 2. Reason for change viz. Mr. Berjis Desai has expressed his unwillingness to seek re- appointment, appointment at the ensuing 20th Annual General Meeting reappointment, (“AGM”) of the Company, consequent to his appointment resignation, removal, at Member of National Commission for Minorities, death or otherwise Government of India, New Delhi. 3. Date of appointment/ At conclusion of the ensuing annual general meeting - reappointment/ cessation September 21, 2026. (as applicable) & term of appointment 4. Brief profile (in case of Not Applicable appointment) 5. Disclosure of Relationship Not Applicable between Directors (in case of appointment) Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 (cid:34)(cid:79)(cid:79)(cid:70)(cid:89)(cid:86)(cid:83)(cid:70)(cid:1)(cid:14)(cid:1)B BERJIS DESAI LL.M (Cantab) Solicitor & Advocate High Court, Bombay August 5, 2026 The Board of Directors, lnventurus Knowledge Solutions Limited, Navi Mumbai. Dear Sirs, My directorship is coming up for re-appointment at the forthcoming Annual General Meeting of the Company. The Government of India has appointed me as Member, the National Commission for Minorities, New Delhi. This appointment requires me to be in the employment of the Government of India. It also requires me to spend a substantial amount of time in New Delhi. in light of the above, I am unabie to offer myself for reappointment as a Director. I take this opportunity to express my gratitude and thanks for the co-operation and support of the Directors and the management of the Company. Needless to add that I shall be available for any inputs or other assistance you may require. It is clarified for the removal of doubt that I shall continue to be a Director until the expiry of my term of office at the forthcoming AGM. Yours sincerely, 91 98210 12035: 91 98334 43178 : berjis@berjisdesai.com 704 Dalamal House, Jomnalal Bajaj Marg, Nariman Point, Mumbai 400021 Indio www.beriisdesai.com II<S HEAL TH Annexure – C DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026 Disclosure of Change in Designation of Director Sr. No. Particulars Details 1. Name of Director Clarence Carleton King II 2. Reason for change viz. Change in Designation appointment, reappointment, resignation, With effect from the conclusion of the ensuing 20th AGM removal, death or otherwise and consequent to the retirement of Mr. Berjis Desai as Non-Executive Chairman and Non-Independent Director, Mr. Clarence Carleton King II, Independent Director shall be designated as Non-Executive Chairman and Independent Director of the Company. 3. Date of appointment/ At conclusion of the ensuing annual general meeting - reappointment/ cessation September 21, 2026 (as applicable) & term of appointment 4. Brief profile (in case of Mr. Clarence Carleton King II (Carl) is a senior health care appointment) executive with 40 years of diverse experience. His deep expertise in health care financing and delivery allows Carl to understand the health care system holistically from the perspective of numerous participants. On the delivery side, Carl has run hospitals, clinics and ambulatory surgery centers. On the financing side, he has run HMOs, PPOs and other types of managed care plans. Carl has worked for publicly traded, privately held and provider-sponsored companies. Over the course of his career, he ran local, regional and national organizations with profit and loss responsibility ranging from a few million dollars to over nine billion dollars annuall [Showing first 8,000 characters — download PDF for full document]